Skip to main content
Earnings Labs
EP

Eupraxia Pharmaceuticals Inc. (EPRX)

NASDAQ·Healthcare·Biotechnology

$7.09

+2.32%

Mkt Cap $451.28M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (5 analysts)

$17.50

Range $11.00 – $25.00

Implied Upside

+146.8%

Consensus $17.50 vs current $7.09